Vaishampayan, U., Thakur, A., Rathore, R., Kouttab, N., & Lum, L. G. (2015). Phase I Study of Anti-CD3 x Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients. Prostate Cancer.
Chicago-stil citatVaishampayan, Ulka, Archana Thakur, Ritesh Rathore, Nicola Kouttab, och Lawrence G. Lum. "Phase I Study of Anti-CD3 X Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients." Prostate Cancer 2015.
MLA-referensVaishampayan, Ulka, et al. "Phase I Study of Anti-CD3 X Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients." Prostate Cancer 2015.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.